WEST PHARM.SVCS DL-,25/ US9553061055 /
06/09/2024 21:44:12 | Chg. -1.900 | Volume | Bid21:59:49 | Ask21:59:49 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
268.600EUR | -0.70% | - Turnover: - |
267.700Bid Size: 66 | 268.600Ask Size: 66 | 19.45 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 7.98 USD | 1.40% |
EPS Diluted: | 7.88 USD | 1.94% |
Revenues per Share: | 40.24 USD | 3.34% |
Book Value per Share: | 39.30 USD | 8.53% |
Cash Flow per Share: | 10.59 USD | 8.48% |
Dividend per Share: | 0.78 USD | 5.41% |
Total | in mill. | |
Revenues: | 2,949.80 USD | 2.18% |
Net Income: | 593.40 USD | 1.28% |
Operating Cash Flow: | 776.50 USD | - |
Cash and Cash Equivalents: | 853.90 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 37.25 | 44.13 |
P/S Ratio: | 7.39 | 8.75 |
P/BV ratio: | 7.56 | 8.96 |
P/CF Ratio: | 28.06 | 33.24 |
PEG: | 26.65 | 31.57 |
Earnings Yield: | 2.68% | 2.27% |
Dividend Yield: | 0.26% | 0.22% |
Market Capitalization | ||
Market Capitalization: | 19.45 bill. EUR | 23.38 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 72.54 mill. |
Profitability
Gross Profit Margin: | 38.28% |
EBIT Margin: | 22.92% |
Net Profit Margin: | 20.12% |
Return on Equity: | 20.60% |
Return on Assets: | 15.50% |
Financial Strength
Liquidity I / Cash Ratio: | 1.27% |
Liquidity II / Quick Ratio: | 2.03% |
Liquidity III / Current Ratio: | 2.88% |
Debt / Equity Ratio: | 0.07% |
Dynam. Debt / Equity Ratio: | 122.15% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |